Product Description: Pivmecillinam-d9 is deuterated labeled Pivmecillinam (HY-B0810). Pivmecillinam (FL-1039) is an orally active proagent of mecillinam, an extended-spectrum penicillin antibiotic.
Applications: COVID-19-immunoregulation
Formula: C21H24D9N3O5S
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216./[2]Nicolle LE. Pivmecillinam in the treatment of urinary tract infections.
J Antimicrob Chemother. 2000 Aug;46 Suppl A:35-39./[3]Graninger W. Pivmecillinam--therapy of choice for lower urinary tract infection. Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:73-8./[4]Holme E, et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989 Aug 26;2(8661):469-73.